The pursuit of improving therapies for eye diseases underscores the high value people place on vision. A 2016 UK survey indicates a willingness to trade significant years of life for sight, highlighting the emotional attachment to vision. Progress in treatments for age-related macular degeneration, such as new drugs and gene therapies, is underway. Additionally, teaching echolocation and utilizing AI for early diagnostic tools show promise in enhancing the quality of life and prevention of severe visual impairments.
Humans are endowed with a powerful suite of senses, but it is vision that is valued the highest.
A 2016 survey revealed that people would rather live 4.6 years in perfect health than 10 years without sight, showcasing the importance of vision.
The scale of work being done to prevent and treat sight loss reflects the strong feelings about the fear of losing sight.
Therapies for age-related macular degeneration are advancing rapidly, with new options like gene therapy potentially changing the treatment landscape.
Collection
[
|
...
]